SC 13G/A:超过5%持股股东披露文件(修正)-Bellevue Capital Management LLC(50.4%),Kuk Hyoun Hwang(50.4%)等
3:首次持股声明-董事 Kim Sang Hyun
3:首次持股声明-董事 Lee Phil Geon
Bellevue Life Sciences Acquisition Corp. | SC 13G:超过5%持股股东披露文件-Bellevue Global Life Science Investors, LLC(36.2%),Bellevue Capital Management LLC(36.2%)等
Bellevue Life Sciences Acquisition Corp. | SC 13G/A:超过5%持股股东披露文件(修正)-Space Summit Capital LLC(0%)
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明-首席执行官 Hwang Kuk Hyoun
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明-首席财务官 Yoo David Jin
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明-股东 Bellevue Global Life Science Investors LLC
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明
Bellevue Life Sciences Acquisition Corp. | 4:持股变动声明
Bellevue Life Sciences Acquisition Corp. | SC 13G:超过5%持股股东披露文件-Space Summit Capital LLC(6.67%)
Bellevue Life Sciences Acquisition Corp. | 3:首次持股声明-其他相关方 Chung In Chul
Bellevue Life Sciences Acquisition Corp. | 3:首次持股声明-其他相关方 Roberts Rad
暂无数据